logo

For the Inventor, By the Inventor

Carmel, IN, United States of America

Mei-Huei T Lai

This inventor holds 5 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1988-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei-Huei T Lai. Retrieved from https://idiyas.com/inventor/mei-huei-t-lai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 115(Granted Patents)


Company Filing History:

goldMedal5 out of 4,517 
 
Eli Lilly and Company
 patents

Years Active: 1988-1999

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6001810 - Methods for treating retroviral infection (1999-12-14),
2. 5270040 - Vectors and compounds for expression of human protein C (1993-12-14),
3. 5235039 - Substrates for HIV protease (1993-08-10),
4. 5151268 - Methods of using recombinant human protein C (1992-09-29),
5. 4775624 - Vectors and compounds for expression of human protein C (1988-10-04),

Title: Innovations by Mei-Huei T Lai

Introduction

Mei-Huei T Lai is a prominent inventor based in Carmel, IN (US). She has made significant contributions to the field of medicine, particularly in the treatment of retroviral infections. With a total of 5 patents to her name, her work has had a substantial impact on healthcare.

Latest Patents

Among her latest patents are methods for treating retroviral infections. This invention provides antiretroviral methods using specific compounds. Another notable patent involves vectors and compounds for the expression of human protein C. This invention comprises novel DNA compounds that encode human protein C activity. A variety of eukaryotic and prokaryotic recombinant DNA expression vectors have been constructed that include the novel protein C activity-encoding DNA. These vectors drive the expression of protein C activity when transformed into an appropriate host cell. The recombinant-produced protein C activity is useful in the treatment and prevention of various vascular disorders.

Career Highlights

Mei-Huei T Lai is currently employed at Eli Lilly and Company, where she continues to innovate and contribute to medical advancements. Her work has been recognized for its potential to improve treatment options for patients suffering from serious health conditions.

Collaborations

Some of her notable coworkers include Nils U Bang and Robert J Beckmann. Their collaborative efforts have further enhanced the research and development of innovative medical solutions.

Conclusion

Mei-Huei T Lai's contributions to the field of medicine through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in healthcare and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…